eu glaucoma drugs market

EU Glaucoma Drugs Market, by Disease Indication (Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma, Others) and by Drug Class (Prostaglandin Analogs (PGAS), Alpha Agonist, Beta Blockers, Cholinergic Drugs, Carbonic Anhydrase Inhibitors, Others) Growth, Trends and Forecast, 2019-2028

  • Published Date: 2022-12-26
  • Report ID: 138183
  • Pages: 200
  • Format: prudent report format

Report Overview

The EU Glaucoma Drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Glaucoma is inherited diseases that damage the eyes optic nerve and can result in optic damage and vision loss. However, with early detection and treatment, you can often protect your eyes against serious vision loss. It is often related to a buildup of pressure inside your eye



Market Drivers

Glaucoma rising geriatric population in Europe are the major driving factors for the glaucoma drugs market in Europe. Increasing blindness in Europe is also a bigger driving factor for glaucoma drugs market


1. EU Glaucoma Drugs Market Overview
A. Market Size
2. EU Glaucoma Market Growth Drivers
I. Rising geriatric population in Europe
II. Increasing blindness in Europe
3. EU Glaucoma Market Segmentation.
A. By Disease Indication
I. Closed angle glaucoma
II. Open angle glaucoma
III. Secondary glaucoma
IV. Congenital glaucoma
V. Others
B. By Drug Class
I. Prostaglandin analogs
II. Alpha agonist
III. Beta blockers
IV. Cholinergic drugs
V. Carbonic anhydrase inhibitors,
VI. Others
4. EU Glaucoma Market Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Allergan Company overview, Product & Services, Strategies & Financials
B. Pfizer Company overview, Product & Services, Strategies & Financials
C. Merck Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Market Opportunities and Future Trends
A. Market Opportunities
B. Future Trends
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.